A microtitre plate based enzyme-linked immunosorbent assay for determining the concentration of serum amyloid A (SAA) is described. The method employs easily produced sequence-specific rabbit antibodies and the preferential absorption of SAA to polystyrene, which obviates the use of capture antibodies and allows an assay time of only 3· 5 h, so that the diagnostic potential of the SAA level as a rapid and reliable marker for inflammation can be fully exploited. The assay has a working concentration range of O· 1-2500 mg/L, which embraces the known biological variation of the SAA concentration. The intra-assay coefficient of variation (CV) for SAA concentrations above 10 mg/L is between 1· 6 and 3' 3OJo and the interassay CV between 3'0 and 4'2%. Recovery of SAA added to serum is from 96 to 102%.
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The serum concentration of the apolipoprotein SAA increases rapidly and up to lOoo-fold in inflammatory conditions.' Although an increased level of SAA is at least as specific and sensitive for inflammatory activity as an increased level of CRP ,1-4 determination of the serum SAA level has not become generally used for routine clinical diagnostic work. This has mainly been caused by the difficulty in producing useful antisera against human SAA. S Immunization of large numbers of animals with the use of many booster injections is usually necessary to obtain a few antisera with acceptable titres and subsequent extensive absorption has generally to be used to attain the required specificity. [6] [7] [8] [9] These difficulties were illustrated by the lack for several years of commercial sources for antisera useful for quantitation of human SAA.S. lO Recently, several attempts have been made to overcome the difficulties in producing antisera against SAA by using immunization procedures employing SAA-related synthetic peptides. 1O -12 It proved easy to raise such sequence-specific antisera and they were useful for demonstrating SAA, and its proteolytic product amyloid A Correspondence: Dr Martin-Tina Casl. 278 protein (AA), in immunohistochemical and immunoblotting techniques. However, such antisera were not generally useful for the quantitation of native SAA. The present work describes a procedure for quantitation of the level of native SAA in serum based upon the use of such easily produced sequence-specific antisera. The procedure utilizes the fact that native SAA preferentially binds to the surface of certain microtitre plates with a resulting exposure of the relevant sequence-specific epitopes and obviating the use of capture antibodies. The procedure can be completed in a few hours so that the rapid increase of the level of SAA in inflammatory conditions can be fully exploited for clinical purposes.
MATERIALS

Specimens
Serum samples were obtained from healthy adult volunteers, blood donors and patients suffering from myocardial infarction, pneumonia, bacterial meningitis, urinary tract infections, juvenile rheumatoid arthritis, acute leukaemia or polytrauma. The samples were analysed within 6 h or stored at -2Qoe until analysed.
Reagents
Peroxidase-labelled goat antibodies against rabbit IgG, bovine serum albumin (BSA), and ammonium-2,2' -azino-bis(3-ethylbenzthiazoline-6-sulphonate) (ABTS) were obtained from Sigma Chemical Company (St Louis, Montana, USA), Ultrogel AcA 34 from IBF, (Villenueve-La-Garrene, France), isolated human polyclonal IgG from the Institute of Immunology (Zagreb, Croatia) and isolated lyophilised human apolipoprotein A-I (Reference material No. 393)from the Commission of the European Communities, Community Bureau of Reference. The apolipoprotein A-I was purified from fresh human plasma by ultracentrifugation followed by delipidation and preparative gel permeation high performance liquid chromatography. Unlisted chemicals were all of analytical grade and obtained from Kemika (Zagreb, Croatia).
A solution containing 480 mg/L of isolated SAA in O' 1 mollL sodium bicarbonate was kindly donated by Dr G Marhaug (University of Trornse, Norway). The SAA was isolated from the serum of a patient with rheumatoid arthritis by ultracentrifugation, gel-filtration and ion-exchange chromatography as described.P The concentration of isolated SAA was determined by quantitative amino acid analysis. This SAA solution was used as primary standard.
A secondary SAA-standard was obtained by pooling serum samples with high concentrations of SAA and storing aliquots of the pool at -2QcC until used. The SAA concentration was determined by calibrating it against the primary standard in the ELISA procedure described below.
Antiserum against the nonapeptide SDARENIQR, corresponding to residues 59-67 of SAA, was raised in rabbits as earlier described, and the antibodies affinity isolated by the use of a column of the nonapeptide coupled to agarose beads." Equipment Cooke 96-well polystyrene microtitre plates were obtained from Dynatech Laboratories (Alexandria, Virginia, USA). For pipetting into the rnicrotitre plates an Eppendorf multipipette with a Plus/8 eight-channel adaptor was used except for addition of antigen, for which a fixed-volume one-channel pipette was used. For washing and reading of the microtitre plates, a Skatron automated washer from Labasco Inc, (Gothenburg, Sweden) and a manually operated portable MR250 reader from Dynatech Laboratories were used.
METHODS
Gel chromatography
One millilitre of a serum pool from 10 healthy individuals was applied to a column (9 x 600 mm) of Ultrogel AcA 34 in 50 mmollL Tris buffer, pH 7· 8, containing 150 mmollL NaCI. Elution at 6 mL/h was performed with the same buffer at room temperature and fractions of 1 mL were collected.
Analytical agarose gel electrophoresis
The procedure described by Jeppsson et al. was used.!" Quantitation of SAA by single radial immunodiffusion The procedure described by Chambers and Whicher" was used. The precipitating antiserum employed was produced in rabbits by immunisation with apo-SAA adsorbed to acid-treated bacteria (Salmonella minnesota R595)IS and was kindly donated by Dr F C de Beer, (University of Stellenbosch, South Africa).
New enzyme-linked immunosorbent assay for SAA All reagents were diluted in 50 mmollL Tris-HCl buffer, pH7'8 containing 150mmollL NaC!, O' 25 mmollL thimerosal and 1070 (wIv) BSA (Tris-BSA buffer). 1. One hundred microlitre aliquots of test samples diluted 1 : 500 and 1: 5000 and seven standard samples with SAA-concentrations between 4 and 500 /Lg/L were incubated in the wells of polystyrene microtitre plates for 1 h at 37 cC. A dilution buffer of 20 mmollL Tris-HCl, pH 7' 8, with 150 mmollL NaCI (Tris buffer) was used. The wells were then washed five times with 200 /LL-aliquotsof 150 mmollL NaCI. 2. Two hundred rnicrolitre aliquots of Tris-BSA buffer were then incubated in the wells for 15 min at 37 cC and the wells subsequently washed five times with 200 /LL-aliquots of 150 mmollL NaC!. 3. One hundred microlitre aliquots of isolated sequence-specific antibodies (0'023 mg/L) were then incubated in the wells for 1 hat 37 CC and the wells thereafter washed five times with 200 /LL-aliquots of 150 mmollL NaCI. 4. One hundred microlitre aliquots of peroxidaselabelled goat anti-rabbit IgG antibodies, diluted 1 : 200, were then incubated in the wells for 30 min at 37 cC and the wells thereafter washed five times with 200 /LL-aliquotsof 150 mmollL NaC!.
5.
One hundred microlitre aliquots of cold (5°-lO°C) 100 mmol/L sodium citrate buffer, pH 4' 0, with 110rng/L ABTS and O·5 mmol/L hydrogen peroxide were then added to the wells with 5 s intervals. The absorbance of each well was read at 405 nm after 30 min incubation against a blank mixture in which the sample was replaced by Tris buffer. The standard curve obtained was used to calculate the SAAconcentrations in the test samples.
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Statistical analysis
The Wilcoxon rank sum test was used to evaluate differences between groups. Differences were considered significant when P-values < O·05 were obtained in the two-tailed test.
RESULTS
The apolipoproteins, including SAA, of high density lipoprotein are known to be preferentially adsorbed from plasma and serum onto polystyrene surfaces.Pi" It was therefore decided to try to construct an enzyme-linked immunosorbent assay (ELISA) for SAA without the use of capture antibodies in order to simplify and speed up the procedure.
A pool of serum from patients with intense acute-phase reactions was used, in addition to a solution of isolated SAA, for optimisation of the ELISA procedure. After establishment of the final ELISA procedure, the SAA concentration of the pool (254 mg/L) was determined by comparing its reaction in the ELISA procedure with that of the solution of isolated SAA. normal serum with low SAA concentration was added to the dilution buffer, a different type of dose-response curve with lower absorbancies resulted ( Fig. 1 ). In an effort to characterize the quenching molecules, normal serum was gel filtered on a column of Ultrogel AcA 34 and the protein content of each fraction analysed by agarose gel electrophoresis. Four parts of each fraction were mixed with one part of a serum pool containing 100 I£g/L SAA and the ELISA procedure described in the methods section was used to measure the SAA concentrations in the mixtures. Figure 2 displays the elution volume of those serum proteins which quench the colourdevelopment. Both the elution volume and the agarose gel electrophoretic analysis indicated that
Ve (mt.) Dose-response curves A solution of isolated SAA and a serum pool with high (254 mg/L) SAA concentration were serially diluted with Tris buffer and 100 I£L aliquots of the dilutions incubated in the wells of polystyrene microtitre plates for 1 h at 37°C. The wells were then washed and incubated with sequence-specific rabbit antibodies against SAA followed by peroxidase-labelled goat antibodies against rabbit IgG and finally by a substrate solution as described in the methods section. Two parallel dose-response curves were obtained when the resulting absorbancies of the wells were plotted against the dilutions of the two samples (Fig. 1) . The corresponding dose-response curves for 11 randomly selected serum samples with high SAA concentrations were all parallel with those depicted in Fig. 1 IgG and HDL were the dominating proteins in the quenching fractions. The SAA concentration in serial dilutions in buffer of a serum pool with high SAA concentration was therefore measured by the ELISA procedure before and after addition to the dilutions of isolated apolipoprotein A-I or polyclonal IgG to final concentrations of 2 and 10 giL, respectively. As can be seen from Fig. 3 apolipoprotein A-I is, in contrast to IgG, quenching the colour development. For a quantitative investigation of the quenching in the ELISA procedure caused by normal serum (with low SAA concentration), a serum pool with high SAA concentration was diluted with Tris buffer containing different concentrations of normal serum and the corresponding doserespose curves in the ELISA procedure registered. Fig. 4 demonstrates that a final concentration of normal serum of O·20/0 (v/v) causes no detectable quenching of the colour development and that accurate results in the ELISA procedure for serum samples thus can be obtained if the samples are prediluted 1: 500 or more. To ascertain that a predilution of 1: 500 also allows determination of the SAA concentration in samples with high levels of apolipoprotein A-I, the SAA concentration was measured in several samples with apolipoprotein A-I levels in the upper normal range (about 2 g/L). Predilutions of these samples 1: 500 and 1: 200 did not produce different results and the ELISA procedure therefore allows the accurate quantitation of SAA in samples with apolipoprotein A-I concentrations up to at least about 5 giL.
Sample incubation time
A serum pool with high SAA concentration was serially diluted and 100 JLL aliquots of the dilutions incubated for O' 5, 1'0 or 2·0 h at 37°C in the wells of microtitre plates. All dilutions were higher than 1: 500. Washing and incubation with primary and secondary antisera and with substrate solution were then performed as described in the methods section. The resulting absorbancies show that a sample incubation time of 1 h is sufficient to produce a dose-response curve which is linear up to at least 500 JLg/L.
Primary antiserum incubation time
A serum pool with high SAA concentration was serially diluted with Tris buffer and 100 JLL aliquots of the dilutions incubated for 1·0 h at 37°C in the wells of microtitre plates. All dilutions were higher than 1: 500. The wells were then washed five times with 200 JLL aliquots of Figure 6 shows a typical standard curve for the final assay procedure using a serum pool with high SAA-Ievel (254 mg/L) as the secondary SAAstandard. This standard curve allows accurate readings in the concentration range 0·2-500 /Lg/L. If two dilutions, 1: 500 and 1: 5000 of all serum samples routinely are analysed, this means a practical working range of 0'1-2500 mg/L. 
Non-specific binding of primary and secondary antisera
Two hundred microlitre aliquots of 50 mmollL Tris-HCl buffer, pH 7 '8, with 150 mmollL NaCl and O· 25 mmollL thimerosal and with varying concentrations of bovine serum albumin were incubated in the wells of microtitre plates for 15 min at 37°C. Washing and incubation with primary and secondary antisera and with substrate solution were then performed as described in the methods section with the exception that the bovine serum concentration in the Tris-BSA buffer used to dilute primary and secondary antibodies was adjusted to correspond to that of the buffer used for the first incubation step. Figure 5 displays that a bovine serum albumin concentration of 111/0 (w/v) is required for a low non-specific colour production in the ELISA procedure.
Sensitivity
The detection limit of the final assay procedure, defined as the minimal concentration of isolated SAA which produces an absorbance greater than the mean plus two standard deviations of the blank values, was determined to be 200 ng/L. Since serum samples must be prediluted at least one in 500 with Tris buffer before analysis, this corresponds to a sensitivity of O· 1 mg/L for serum samples.
Secondary antiserum incubation time
A serum pool with high SAA concentration was serially diluted with Tris buffer and 100 /LL aliquots of the dilutions incubated for 1·0 h at 37°C in the wells of microtitre plates. All dilutions were higher than 1: 500. The wellswere then washed five times with 200 /LL-aliquots of 150 mmollL NaCI and incubated with 200 /LL aliquots of Tris-BSA buffer for 15 min at 37°C. After washing of the wells five times with 200 /LL-aliquots of 150 mmol/L NaCl, 100 /LL aliquots of isolated sequence-specific antibodies (0'023 mg/L) in Tris-BSA buffer were added to the wells and incubated for 1'0 h at 37°C. One hundred microlitre aliquots of peroxidase-labelled goat anti-rabbit IgO antibodies, diluted 1: 200 in Tris-BSA, were then incubated in the wells for 0'5 or 1'0 h at 37°C. Subsequent washing and incubation with substrate solution were then performed as described in the methods section. The resulting absorbancies demonstrate that an incubation time for the secondary antiserum of O·5 h is sufficient to produce a dose-response curve which is linear up to at least 500 /Lg/L. 10'0,50'0,150 and 250mg/L. The coefficient of variation (CY) of the results varied between l' 60/0 and 3· 3%. The inter-assay variability was determined by repeating the measurements of the same serum samples on 10 separate days. In this case the CY was between 3· 0% and 4· 2%. The experiments were repeated on a serum sample with a SAA concentration of 1·0 mg/L and the intra-and inter-assay CYs were found to be 16 and 24%, respectively.
Recovery
Three serum samples with known high SAAconcentrations were mixed in various proportions with three samples with known low SAAconcentrations and the SAA-concentrations of the mixtures determined. The results obtained were between 96 and 102% of those expected.
Sample storage
Seven serum samples with SAA-concentrations between 52 and 2040 mg/L were analysed by the ELISA procedure immediately after coagulation and after five cycles of freezing and thawing at 37°C. No statistically significant difference between the results obtained before and after the freezing-thawing cycles was found. However, overnight storage of the samples at 4°C caused a significant reduction ranging between 10 and 20% of the values obtained.
Reference values
The SAA-concentration in serum samples from 30 healthy adult volunteers was measured by the ELISA procedure and the results ranged between < O' 1 and 1· 2 mg/L with a mean value of O'8 mg/L. When the SAA-levels in serum samples from 60 healthy blood donors were investigated the values were significantly higher and ranged between 6' 3 an 31 mg/L with a mean value of 16'7 mg/L.
Method comparison
The SAA-concentrations in 47 serum samples from healthy and diseased persons were measured both by the new ELISA procedure and by single radial immunodiffusion, employing a precipitating rabbit antiserum. The same secondary SAAstandard of pooled serum samples were used in both procedures. As demonstrated in Fig. 7 , the values obtained closely agree.
DISCUSSION
In a study comparing four methods for quantitation of SAA, it was noted that those three methods (two ELISA procedures and one solid-phase radioimmunoassay), which employed microtitration plates, were seriously disturbed by non-antibody mediated adsorption of SAA from the samples onto the polystyrene or polyvinylchloride surfaces." The problem was more pronounced when samples with high SAA concentrations were investigated and could not be solved by the use of monoclonal antibodies. A subsequent study of the interaction between plasma proteins and biomaterial surfaces demonstrated that high density apoliproteins are preferentially adsorbed to polystyrene and polyvinylchloride surfaces. IS These observations are exploited in the present work for the establishment of an ELISA procedure for quantitation of SAA. The adsorption of SAA to the microtitre plate has three consequences which all are advantageous. First, it obviates the use of capture antibodies with a concomitant reduction of the assay time. Secondly, it denatures the SAA so that it reacts with easily produced sequence-specific antibodies as well as with polyclonal antisera raised against isolated SAA. lO , 17 Thirdly, SAA populations with different physicochemical properties, e.g, the populations in high density lipoproteins of serum samples and those in standards of delipidated and denatured isolated SAA will be transformed into physicochemically simil~r, if not identical, populations by their absorption to the same type of surface.
During development of the ELISA procedure, it was observed that parallel dose response curves were obtained for serum samples with high SAA levelsand for solutions of isolated SAA. However, addition of high concentrations of normal serum (with low SAA level) to the dilution buffers produced quenching of the dose response curves. This was interpreted as evidence for the presence in normal serum of molecules competing with SAA for binding to the microtitre plate surface. By addition to SAA solutions of fractions obtained on gel chromatography of normal serum, IgG and apolipoprotein A-I could be identified as possible competing molecules and addition of the isolated proteins to SAA solutions established the competitive role of apolipoprotein A-I. Earlier investigations have shown that apolipoprotein A-I is preferentially adsorbed from serum onto polystyrene microtitre plates and that it quenches the coating of such plates with other serum proteins . 16 The reason for the different dose response curves obtained in the ELISA procedure for normal serum samples with low SAA levelsand serum samples from patients with inflammatory diseases and high SAA levelscan thus be explained by the highly different SAA/apolipoprotein A-I molar ratios of such samples. If the total amount of available adsorption sites in the wells of the microtitre plates is less than the sum of apolipoprotein A-I and SAA molecules in the samples, a situation will result in which the dose response curves will be dependent upon the SAAI apolipoprotein A-I molar ratio of each specific sample. On the other hand, if all samples are diluted to such a degree that the sum of apolipoprotein A-I and SAA molecules in each well is considerably below the amount of available adsorption sites, no competition willoccur and the dose response curves for all samples will be identical. Investigation of dose response curves at different serum dilutions strongly indicated that a 1: 500 predilution of serum samples is sufficient to produce such a favourable ratio between the amounts of adsorption sites and apolipoprotein A-I and SAA molecules that identical dose response curves will be obtained for serum samples with both high and low SAA levels. Although such a predilution step decreases the overall sensitivity of the ELISA procedure, it will still allow determination of the SAA-level in the vast majority of normal serum samples. It should be pointed out, however, that if the ELISA procedure is to be used for samples other than serum, e.g. solutions of purified high density lipoproteins, it is necessary to perform dilution experiments to establish conditions giving an excess of binding sites in the micro titre wells.
The protein binding properties of different types of polystyrene microtitre plates may vary.
Ann Clin Biochem 1993: 3D Such a variation seems to be valid also for the binding of SAA, since we have observed that different types of standard curves are obtained in the ELISA procedure, when different types of microtitre plates are used. For example, while the Dynatech microtitre plates Cooke, M29A and M29AR allowed construction of standard curves spanning large concentration ranges, this was not the case for lmmulon I, II, III and IV microtitre plates.
The serum concentration of SAA may increase within a few hours after the onset or aggravation of an inflammatory process. 18, 19 To fully exploit the potential of the serum level of SAA as a sensitive and rapid marker for inflammation, it is therefore required that the procedure to determine the SAA levelcan be completed within a few hours. This is not the case for the radioimmunoassays, ELiSAs and single radial immunodiffusion procedures so far described. 4 , 12.13, 17,20-22 However, the ELISA procedure described in the present work does not require the use of capture antibodies, is run at 37°C and does not require a denaturationl delipidation step. It can therefore be completed in only about 3' 5 h. As it also allows simultaneous handling of large number of samples, it is suitable for rapid mass analysis of SAA. In a literature survey, we only found one additional report on a method allowing quantitation of SAA within a few hours.P Although this nephelometry-based assay is as rapid as the presently described ELISA procedure, its sensitivity and measuring range are considerably lower and it requires, like most nephelometric procedures, that turbid samples are delipidated before analysis.
In its native state in serum, SAA is mainly present as an apolipoprotein of the high density lipoproteins. In several methods for quantitation of SAA, the reaction of this population of native SAA with an antiserum is compared with the reaction between the same antiserum and a population of isolated and denaturated SAA. Two SAA populations with considerable physicochemical and immunochemical differences are thus compared. This may result in different dose response curves and difficulties in comparing results obtained with different methods. In an effort to improve the situation, it was suggested that a population of isolated, SAA-rich, native high density lipoprotein should be used for standardization purposes." However, to use a standard SAA population which is similar in physicochemical and immunochemical properties with the SAA populations in serum samples is not the only possible way of increasing the accuracy and reproducibility of methods for quantitation of SAA. For if the quantitative method contains a step, which transforms the differing populations into populations with identical, or similar, properties, the states of the original populations do not matter. It is probable that such a transformation is brought about by the adsorption step of the ELISA procedure for SAA quantitation described in this work, since parallel dose response curves are obtained for all tested serum samples and a solution of isolated and denatured SAA. Another indication for this is that the results obtained for the SAA-Ievels in serum from blood donors and other healthy individuals agree with the results obtained by several other methods for SAAquantitation. 13 ,21-26 It is therefore possible that the results of the presented ELISA procedure will be largely uninfluenced by the properties of the SAA standard used.
